top of page

Nintx at SWITCH | Singapore Week of Innovation and Technology

Writer: Nintx
Nintx
Nov 2
1 min read

Our CEO, Stephani Saverio, spent an inspiring week in Singapore, connecting innovation, science, and new opportunities for Nintx


Nintx is grateful to the Embassy of Brazil in Singapore for selecting the company to join this innovation mission and for the opportunity to participate in SWITCH. Our CEO, Stephani Saverio, participated of an event that brought together remarkable technological advances, entrepreneurs, investors, and global innovation leaders.


“It was a privilege to present Nintx across different forums, including investor pitching sessions, and explore exciting opportunities for our next stage of growth.

Beyond the event, we had productive discussions on potential scientific collaborations with institutions such as A*STAR - Agency for Science, Technology and Research, as well as licensing opportunities for NTX-06, our lead drug candidate for Inflammatory Bowel Disease (IBD), which is entering clinical trials this month. We also engaged with potential pharmaceutical partners interested in following the clinical study and exploring licensing opportunities based on its results”, declared Saverio.


Asia’s rich heritage in natural products, combined with its rapidly advancing microbiome science ecosystem, makes the region particularly exciting for Nintx’s innovation strategy. Now comes the most important part: turning the connections made and opportunities identified into meaningful partnerships and tangible results.


Go Nintx!


To have access to the full content, check us out on LinkedIn.


 
 
bottom of page